CCR5Δ32 polymorphism effects on CCR5 expression, patterns of immunopathology and disease course in multiple sclerosis
- 31 December 2005
- journal article
- research article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 169 (1-2) , 137-143
- https://doi.org/10.1016/j.jneuroim.2005.07.025
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Clinical implications of benign multiple sclerosis: A 20‐year population‐based follow‐up studyAnnals of Neurology, 2004
- An absence of CCR5 on donor cells results in acceleration of acute graft-vs-host diseaseExperimental Hematology, 2004
- Reduced Macrophage Infiltration and Demyelination in Mice Lacking the Chemokine Receptor CCR5 Following Infection with a Neurotropic CoronavirusVirology, 2001
- CCR5 Δ32, matrix metalloproteinase-9 and disease activity in multiple sclerosisJournal of Neuroimmunology, 2000
- More evidence that founder effects exist in the European populationEuropean Journal of Human Genetics, 1999
- Genetic Restriction of HIV-1 Infection and Progression to AIDS by a Deletion Allele of the CKR5 Structural GeneScience, 1996
- Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor geneNature, 1996
- Homozygous Defect in HIV-1 Coreceptor Accounts for Resistance of Some Multiply-Exposed Individuals to HIV-1 InfectionCell, 1996
- Monocyte/macrophage differentiation in early multiple sclerosis lesionsAnnals of Neurology, 1995
- Suppression of experimental allergic encephalomyelitis in Lewis rats after elimination of macrophages.The Journal of Experimental Medicine, 1990